Related Scientific Literature
- Clinical And Analytical Performance Of An Automated Serological Test That Identifies S1/S2 Neutralizing IgG In Covid-19 Patients Semiquantitatively
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19
- Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays
- Detection of COVID-19: A review of the current literature and future perspectives
- Comparative Evaluation of Three Serologic Assays for the Identification of SARS-CoV-2 Antibodies
- RT-PCR testing to detect a COVID-19 outbreak in Austria: rapid, accurate and early diagnosis in primary care (The REAP study)
- Correlation of ELISA based with random access serologic immunoassays for identifying adaptive immune response to SARS-CoV-2
- Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays?
- Current and Perspective Diagnostic Techniques for COVID-19
- Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
- Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
- Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
- Testing For SARS-CoV-2: The Day the World Turned its Attention to the Clinical Laboratory
- How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing
- Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
- Comparison of different serological assays for SARS-CoV-2 in real life
- Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
- Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody
- Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation
- Antibody response using six different serological assays in a completely PCR-tested community after a COVID-19 outbreak - the CoNAN study
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs
- Clinical Performance of Two SARS-CoV-2 Serologic Assays
- Evaluation of Three Commercial Automated Assays for the Detection of anti-SARS-CoV-2 Antibodies
- Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity
- Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays
- Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies
- High-throughput immunoassays for SARS-CoV-2 – considerable differences in performance when comparing three methods
- Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent sera
- Comparison of SARS-CoV-2 serological tests with different antigen targets
- Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories
- Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
- Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with
- Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection.